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a  b  s  t  r  a  c  t
Macrophages  are  antigen  presenting  cells  that  can  adopt  different  activation  states  as  directed  by
microenvironmental  stimuli.  It is well-recognised  how  CD4+ T  helper  (Th)  signals  drive  macrophage
activation,  but  the  ability  of  differentially  activated  human  macrophages  to stimulate  the  major  types
of CD4+ T helper  (Th)  response  by  presenting  antigen  have  not  been  well  deﬁned.  Previous  studies
have  focussed  on murine  cells,  undifferentiated  human  monocytes,  or  macrophage  products,  and  have
been limited  to non-physiological  mitogenic  Th  responses.  The  aim  was  therefore  to  compare  the Th
cell  polarising  abilities  of  different  human  macrophage  subsets  when  presenting  speciﬁc  antigen.  We
demonstrate  for  the  ﬁrst  time  that  the way  macrophages  are  activated,  while  naturally  presenting
antigen,  has profound  effects  on  downstream  adaptive  immune  responses.  In  autologous  co-cultures,
LPS-activation  was  the  most  potent stimulus  for antigen-loaded  macrophages  to  drive  Th17  polarisation
from  both  unfractionated  CD4+ T-cells  and  the CD45RO+ memory  population,  while  IFN/LPS  activated
macrophages  preferentially  induced  a  Th1  phenotype.  By  contrast,  IL-4-activated  macrophages  were  inef-
fective  in  inducing  responses  by  either  Th subset.  Although  antigen-loaded  dendritic  cells  were  superior
to  macrophages  in  driving  Th1 responses,  the  Th17  polarising  capacity  of  the  two  antigen-presenting
cell types  was  equivalent,  and was strongly  dependent  on IL-1  secretion.  Taken  together,  these  results
clearly  demonstrate  for  the ﬁrst  time  how  differentially  activated  human  macrophages  present  antigen  to
bias  speciﬁc,  rather  than  mitogen-driven,  Th  responses  and  lead  us  to propose  that they  impact  adaptive
immunity  in vivo,  particularly  in determining  Th17  polarisation  within  inﬂamed  tissues.
© 2014  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CCntroduction
Macrophages are key features of inﬂammation, where their
oles include elimination of infection, clearance of debris and
estoration of tissue homeostasis (Murray and Wynn, 2011; Wilson,
010). To fulﬁl these tasks, they can adopt different functional
henotypes dependent on the activating stimuli in their microen-
ironment. The extent of macrophage heterogeneity, and the
olarising stimuli to which they respond, is subject to ongoing
nvestigation, but distinct macrophage subsets have been described
n vitro (Gordon and Taylor 2005; Martinez et al., 2008; Mosser and
dwards, 2008; Murray and Wynn, 2011). For example, classical or
Abbreviations: APC, antigen presenting cell; DC, dendritic cell; KLH, keyhole
impet haemocyanin; PPD, puriﬁed protein derivative; SOCS, suppressor of cytokine
ignalling; TGM2, transglutaminase 2.
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M1-activated macrophages, induced by microbial products in the
presence or absence of IFN-, are microbicidal, tumoricidal and pro-
inﬂammatory. Their dysregulation plays a central role in chronic
inﬂammation and autoimmunity. In contrast, alternative or M2
activation by IL-4 and/or IL-13 gives rise to anti-inﬂammatory,
tissue-remodelling cells. These subtypes are thought, however, to
represent extremes of a continuum of activation states found in
vivo. Although macrophages can act as professional antigen pre-
senting cells (APC), and their heterogeneity impacts this role, it
remains to be determined how efﬁciently each macrophage subset
supports the responses of particular CD4+ helper T (Th) subpopu-
lations, notably the inﬂammatory Th17 type.
T cell differentiation is a central feature of adaptive immune
responses, with polarisation into different subsets highly depend-
ent on the APC and the cytokines they produce (Gutcher and
Becher, 2007). CD4+ helper T (Th) cells adopt different functional
phenotypes characterised by cytokine secretion proﬁles, with, for
example, Th1, Th2 and Th17 populations producing the respective
signature cytokines interferon- (IFN-), interleukin-4 (IL-4) and
IL-17A. Dendritic cells (DCs) are commonly viewed as the most
s article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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otent APC, notably for naïve T cells (Iwasaki and Medzhitov, 2010),
nd are particularly effective at inducing Th1 responses. However,
acrophages are typically the more abundant APC type within
nﬂamed sites, where their numbers, but not those of DC, corre-
ate with Th17 activity (Allam et al., 2011). One interpretation of
hese observations is that macrophages are at least as capable as
C in driving human Th17 responses, but this has not been tested
irectly, nor has the effectiveness of different macrophage subtypes
een compared.
To date, the two-way relationships between different respective
acrophage and Th subsets have been characterised largely from
he perspective of the effects of Th cells on macrophages. Thus,
t is well-reported that Th cell cytokines activate macrophages in
nﬂamed sites, with Th1 and Th2 or T regulatory cells driving M1
nd M2  macrophages, respectively (Gordon and Martinez, 2010;
urray and Wynn, 2011), but much less is known as to which
f the macrophage subsets can drive different Th subpopulations,
specially Th17 cells. In particular, key questions remain about the
ffects on the human Th response when each macrophage subtype
resents antigen. Previous studies have either focussed on mice,
r on LPS-activated human monocytes, macrophage culture super-
atants or exogenously added examples of macrophage-derived
ytokines when T cells respond to mitogenic stimuli such as anti-
D3/CD28 and/or PMA  and ionomycin (Krausgruber et al., 2011;
ondal et al., 2010; Qin et al., 2012; Savage et al., 2008; Walter et al.,
013). Such approaches, although informative, do not fully recapit-
late the natural interactions between the human cell types that
timulate Th cells speciﬁc for presented antigen. Moreover a direct
omparison of differentially activated macrophages on autologous
 cell responses has not been reported.
To address this, the aim was to determine how the activation
tate of human macrophages presenting antigen inﬂuences their
bility to drive responses by different Th subsets. Our results iden-
ify the roles of differentially activated macrophages in shaping Th
ifferentiation in vitro, and deﬁne the macrophage subsets most
ffective in supporting Th17 responses. These relationships have
mportant implications in vivo, particularly for therapeutic manip-
lation of inﬂammation where macrophages are prominent.
aterials and methods
ell isolation
Ethical approval for blood sampling from consenting healthy
olunteers was granted by the Ethics Review Board of the College
f Life Science & Medicine, University of Aberdeen in accordance
ith the declaration of Helsinki. Blood samples were taken by
enepuncture and collected into EDTA vacutainers (Greiner Bio-
ne Ltd, Stonehouse, UK). Peripheral Blood Mononuclear Cells
PBMCs) were isolated by density gradient centrifugation using
ymphoprep (Axis-Shield, Dundee, UK) according to manufac-
urers’ recommendation. Monocytes and T-cells were positively
elected from PBMCs by magnetic-activated cell sorting (MACS),
sing anti-CD14+ and anti-CD2+ MicroBeads (Miltenyi Biotec, Sur-
ey, UK). Memory T-cells were isolated by negative cell depletion
sing CD45RO+ isolation kits (Miltenyi Biotec) and characterised
y expression of CD45RO (Plebanski et al., 1992). Cell purity was
onﬁrmed by ﬂow cytometry and was routinely ≥98% for positive
ell selection and ≥95% for negative cell depletion.
ulture and differentiation of monocytesIsolated monocytes were cultured in 24 well plates
4 × 105 cells/well) in DMEM (Lonza, Basel, Switzerland) sup-
lemented with 2% penicillin/streptomycin (Life Technologies,logy 220 (2015) 10–19 11
Paisley, UK) and 10% heat-inactivated sterile ﬁltered human AB+
serum for 7 days to differentiate into macrophages (Arnold et al.,
2014). Monocyte-derived dendritic cells (mo-DC) were generated
by additional stimulation with 100 ng/mL human recombinant
granulocyte macrophage colony-stimulating factor (GM-CSF) and
20 ng/mL human recombinant IL-4 (PeproTech, London, UK).
Macrophage and mo-DC activation and T-cell co-culture
Macrophages or mo-DC were stimulated with 1 g/mL LPS
(OIII:B4 E.coli, Sigma Aldrich, Poole, UK) alone or in combination
with 20 ng/mL IFN (R&D Systems, Abingdon, UK), or 20 ng/mL
IL-4 for 5 h. Additionally cells were loaded with either recall
antigen 5 g/mL mycobacterial puriﬁed protein derivative (PPD)
(Statens Serum Institute, Copenhagen, Denmark), or primary anti-
gen 10 g/mL keyhole limpet haemocyanin (KLH) (Calbiochem,
Nottingham, UK). PPD readily provokes in vitro recall responses
by T cells from donors who  have been vaccinated with Bacillus
Calmette-Guérin, whilst KLH elicits naïve responses unless subjects
have been deliberately exposed to the antigen (Barker and Elson,
1994; Pickford et al., 2007). Control cells were left untreated or
were loaded with antigen only in the absence of activating factors.
Approximately 1 × 106 autologous T-cells were added per well. T-
cell responses have been determined to peak at day 5 in response
to PPD and at day 8 in response to KLH (Barker and Elson, 1994;
Pickford et al., 2007).
T-cell proliferation assay
Cells from co-cultures were incubated with [3H]-thymidine
(Amersham, Bucks, UK) in 96-well plates in triplicates for 6 h.
DNA of cells was  harvested onto glassﬁbre-ﬁltermats by vacuum-
manifold, and proliferation measured with a Trilux-Beta-counter
LKB-WALLAC, Turku, Finland) in corrected counts per minute
(CCPM).
RNA isolation and qPCR
Total cellular RNA was isolated from untreated or cytokine-
stimulated human monocyte derived macrophages using Trizol
(Life Technologies) extraction and cleaned up using the RNeasy
mini kit (Qiagen, Manchester, UK). The concentration of RNA was
assessed by spectrophotometry using the NanoDrop-100. Five hun-
dred nanograms of RNA was reverse transcribed into cDNA using
Oligo dT 15 Primer (Promega, Southampton, UK) and Superscript
II (Life Technologies). The following primers were used: TNF  ˛ for-
ward (cgctccccaagaagacag); TNF  ˛ reverse (agaggctgaggaacaagcac);
SOCS3 forward (cttcgactgcgtgctcaa); SOCS3 reverse (gtaggtggc-
gaggggaag); IL-6 forward (gatgagtacaaaagtcctgatcca); IL-6 reverse
(ctgcagccactggttctgt); HLA-DR forward (acaactacggggttgtggag);
HLA-DR reverse (gctgcctggatagaaaccac); TGM2 forward (ggcaccaag-
tacctgctca); TGM2 reverse (agaggatgcaaagaggaacg); MRC1 man-
nose receptor forward (ttcagaaggttttacttggagtga); MRC1 mannose
receptor reverse (tctccataagcccagttttca); CISH forward (agccaagac-
cttctcctacctt); CISH reverse (tggcatcttctgcaggtgt). Quantitative real
time PCR was carried out by Lightcycler 480 (Roche) with the
Universal Probe Library system (Roche, West Sussex, UK). Gene
expression was  analysed using the comparative Ct method with
target gene mRNA levels being normalised to GAPDH. All values
represent the mean ± SD of differently activated macrophages com-
pared to non-stimulated cells.Cytokine analysis
ELISA: Supernatants were collected from macrophage/mo-DC-
T-cell co-cultures after 5 or 8 days of culture. Concentrations of
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FN, IL-10 (matched Ab-pairs; BD Biosciences, Oxford UK) and IL-
7A (matched Ab-pair eBioscience, Hatﬁeld, UK) were determined
y ELISA. 96-well/plates (NUNC) were coated with primary anti-
ody at 2 g/mL in 0.1 sodium carbonate buffer pH 9 for 1.5 h at
7 ◦C followed by blocking of non-speciﬁc binding sites with 2%
ovine serum albumin (BSA) in PBS for 1 h at 37 ◦C. Plates were
ashed twice and 100 L/well of culture supernatant was  loaded
nto ELISA plates in duplicates and incubated for 1.5 h at room
emperature. Secondary antibody was applied at 1 g/mL (IFN)
nd 0.5 g/mL (IL-17A) in 0.2% BSA PBS for 1.5 h at room tempera-
ure. Plates were incubated with 100 L/well ExtrAvidin (1:10,000)
Sigma Aldrich) for 1 h followed incubation with phosphatase sub-
trate 1 mg/mL  (Sigma Aldrich) until optimal development was
chieved. Substrate development was measured with Labsystem
ultiscan MS  plate reader and cytokine levels were calculated from
tandard curves generated with Genesis software using a cubic
pline smoothed function.
Cytometric bead array: Supernatants of macrophages and mo-
C was collected 24 h after activation and stored at −80 ◦C until
ssayed. Cytometric Bead Arrays were performed in parallel for IL-
, IL-6 and IL-12p70 (all BD ﬂex kits) according to manufacturer’s
nstructions. The results were acquired on a BD FACSArray.
henotypic analysis of cells by ﬂow cytometry
Macrophages and mo-DC were harvested with dissociation
olution (HBSS 2 mM EDTA, 1 mM sodium citrate) on ice. Cells
ere stained with anti-CD14-APC (Miltenyi Biotec), anti-CD11b-
E, anti-CD11c-Paciﬁc Blue, anti-CD1a-FITC and anti-HLA-DR-FITC
all BD Biosciences) in staining buffer (PBS 2%FCS 2 mM EDTA)
or 30 min. Cytokines secretion from T-cells was blocked by
ddition of 2 mM monensin (eBiosciences) for 10 h prior to
ell staining. T-cells were transferred to 5 mL  ﬂow cytometry
ubes and were ﬁrst stained for extracellular markers using
nti-CD4-Paciﬁc Blue, anti-CCR4-PE-Cy7, anti-CCR6-PerCP-Cy5.5,
nti-CD45RA-AlexaFlour720, (eBiosciences) and anti-IL-23R-FITC
R&D Systems) on ice for 30 min. Cells were ﬁxed and permeabilised
or 20 min  on ice. Cells were stained for intracellular markers
ith anti-IL-17A-APC (BD Biosciences) and anti-RORt-PE (eBio-
ciences) antibodies for 30 min  on ice. Fluorescence of cells was
cquired on LSRII (BD Biosciences) and analysed with FCS Express
De Novo software, Los Angeles, CA).
tatistical analysis
Signiﬁcant differences were calculated with PRISM 5.0 software
Graphpad, San Diego, CA, USA) using a non-parametric paired test
Wilcoxon-Signed-Rank-Test) or as indicated in Figure legends.
esults
ifferentially activated human macrophages show distinct gene
xpression proﬁles
Few studies have compared directly the expression proﬁles of
ctivation markers for different subsets of in vitro generated human
onocyte derived macrophage mainly because these have not
een scrutinised or cannot be agreed upon (Ambarus et al., 2012;
aguin et al., 2013; Martinez et al., 2013; Murray and Wynn, 2011;
ogel et al., 2014). Therefore, we ﬁrst conﬁrmed the difference in
henotypes between LPS-, IFN-/LPS- and IL-4-activated human
acrophages by analysing the gene expression levels of matura-ion markers that have been suggested to be upregulated (Ambarus
t al., 2012; Arnold et al., 2014; Jaguin et al., 2013; Martinez et al.,
013; Murray and Wynn, 2011; Vogel et al., 2014). LPS induced the
xpression of TNF, SOCS3 and IL-6, as compared to non-stimulatedlogy 220 (2015) 10–19
cells (Fig. 1). Activation with IFN-/LPS showed a more potent
effect, with greater mRNA expression of TNF, SOCS3, IL-6 and HLA
DR than that of LPS stimulation alone. In contrast to LPS- and
IFN-/LPS activated macrophages, IL-4 activation increased expres-
sion of the human M2  macrophage markers transglutaminase 2
(TGM2), CISH and macrophage mannose receptor (CD206) but not
of the M1  markers SOCS3, TNF or IL-6. These results identify unique
expression proﬁles that can classify differentially activated human
macrophages, and point to phenotypic differences between our LPS,
IFN-/LPS and IL-4 activated populations that could impact on their
functions.
Differential activation of macrophages presenting antigen shapes
the type of Th response
A primary aim was  to compare the efﬁciency with which anti-
gen presentation by differentially activated human macrophages
drives each of the major types of Th response in vitro. Our
studies were deliberately designed to test the results of antigen-
speciﬁc interactions between macrophages (as oppose to their
monocyte precursors) and autologous Th cells, rather than rely-
ing on more contrived conditions such as unnatural mitogenic
or anti-CD3 activation in the presence of macrophage-derived
cytokines.
Macrophage presentation to stimulate primary responses
The ﬁrst experiments determined the capacity of activated
macrophages to drive naïve Th cell polarisation in response to
a primary antigen, KLH (Barker and Elson, 1994; Pickford et al.,
2007), since such naïve responses are most tractable in terms of
their activation and differentiation. As shown in Fig. 2A, certain
types of activated macrophage pulsed with KLH readily stimulated
T cell proliferation by day 8 of co-culture, conﬁrming the ability
of our system to support responses to primary antigen presenta-
tion. Such relatively extended culture periods have previously been
shown to allow naïve T cell responses to develop (Barker and Elson,
1994; Pickford et al., 2007). LPS or IFN/LPS-activated macrophages
induced signiﬁcantly higher T cell proliferation in response to KLH
compared to those that had not been activated, or had been treated
with IL-4. IL-10 activated macrophages supported only negligible
responses (data not included). Thus, induction of primary T cell pro-
liferation by macrophages is strongly dependent on its activation
status.
Next, the ability of differentially activated, KLH antigen-loaded
macrophages to polarise Th1, Th17 or anti-inﬂammatory cytokine
responses was  compared, by determining the concentrations of
IFN-, IL-17A and IL-10, respectively, in culture supernatants. In all
experiments, the levels of IL-4, indicative of Th2 polarisation, were
low or undetectable (<3 pg/mL). Mirroring their ability to stim-
ulate proliferation, LPS-, and more potently, IFN/LPS-activated
macrophages induced signiﬁcant IFN secretion in co-cultures
(Fig. 2B), consistent with Th1 differentiation, whilst, in contrast,
IL-4-activated macrophages supported only relatively weak IFN
responses. However, a different proﬁle of responsiveness to KLH
presented by each activated macrophage subset was observed
when IL-17A production was  measured. Although again LPS- or
IFN/LPS-, but not IL-4-, activated macrophages induced signiﬁ-
cant IL-17A secretion, LPS stimulation led to the most pronounced
responses (Fig. 2C). IL-10 responses to KLH presentation by the
differentially activated macrophages followed a different pattern,
with LPS activation associated with the highest levels of the
cytokine (Fig. 2D).Overall, the results indicate that T cell responses to macrophages
presenting primary antigen are strongly dependent on the
activation state of macrophages, which dictates both the cytokine
proﬁle and amplitude of Th cell proliferation.
C.E. Arnold et al. / Immunobiology 220 (2015) 10–19 13
Fig. 1. Differentially activated human macrophages show distinct gene expression proﬁles. Human monocyte derived macrophages from the same donor preparation were
cultured with LPS, IFN-/LPS or IL-4 for 5 h and mRNA expression was analysed by qPCR for TNF, SOCS3, IL-6, HLA DR, TGM2, mannose receptor (MR) or CISH. Values
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acrophage presentation to stimulate recall responses
Although we demonstrate above the differential ability of
acrophages to drive polarisation of naïve T cells, in vivo, activated
acrophages at sites of inﬂammation will predominantly contact
emory T cells, the phenotypes of which are less easy to deviate.
e  therefore determined the capacity of differentially activated
acrophages to drive T cell polarisation in response to a recall
ntigen. Macrophages generated from blood of Bacillus-Calmette-
uérin (BCG) vaccinated donors were activated with LPS, IFN/LPS
r IL-4 to induce distinct phenotypes and loaded with mycobacte-
ial Puriﬁed Protein Derivative (PPD), to elicit an antigen-speciﬁc
ecall T cell response.As expected for a recall response, proliferation of T cells peaked
arlier than seen for macrophages presenting naïve antigen KLH,
y 5 days of co-culture, and responses were substantially larger
Fig. 2E). LPS- or IFN/LPS-activated macrophages, loaded withxpression compared to non-stimulated cells. Values are mean ± SD; n = 5 different
PPD, clearly induced signiﬁcant increases in proliferation, while
IL-4-activated macrophages did not. Similarly, LPS- or IFN/LPS-,
but not IL-4-, activated macrophages loaded with PPD stimulated
signiﬁcant increases in IFN secretion (Fig. 2F). The strong Th1
cytokine responses are a typical of mycobacterial challenge, but
the PPD loaded macrophages were also capable of stimulating
IL-17A production (Fig. 2G). As we  saw for KLH stimulation, the
ability to elicit IL-17A by presenting PPD depended on the activa-
tion state of the macrophage, and different macrophage subsets
were most effective for IL-17A and IFN responses. Thus, similar to
KLH loaded macrophages, LPS-activated macrophages presenting
PPD induced the largest increase in IL-17A production as com-
pared to the other macrophages types. IL-10 was also produced,
and was up-regulated in T cell co-cultures with LPS-, IFN/LPS-
, or IL-4-activated macrophages, with signiﬁcant increases in the
former two  (Fig. 2H). The ability of LPS-activated macrophages that
14 C.E. Arnold et al. / Immunobiology 220 (2015) 10–19
Fig. 2. Differential activation of macrophages presenting antigen shapes the proliferation and cytokine secretion of T cells after co-culture. Differences in proliferation and
c ges w
v erenc
d irs tes
p
c
s
m
i
I
m
c
m
r
f
p
rytokine levels of individual donors were based on cultures of T cells and macropha
alue  of control without antigen). Differences where KLH was antigen (A–D); Diff
ifferent  donor preparations. Signiﬁcance was calculated by Wilcoxon-matched pa
resent KLH or PPD to drive IL-17A production is notable, and we
onﬁrmed that the cytokine was produced from a Th17 response,
ince none was detectable (<4 pg/mL) in cultures of LPS-activated
acrophages alone, and ﬂow cytometric staining of co-cultures
dentiﬁed increased proportions of CD4+ cells with a CCR4, CCR6,
L-23R, RORt, Th17 phenotype (Supplementary Figure 1).
In order to conﬁrm that the responses to PPD were mediated by
emory cells, we repeated the experiments with the CD45RO+ T
ell fraction, which represents the antigen-experienced compart-
ent (Plebanski et al., 1992) (Supplementary Figure 2). Similar to theesults obtained using unselected T cell populations, the CD45RO+
raction generated the highest IFN and IL-17A responses when
resented with PPD by IFN/LPS- and LPS-activated macrophages,
espectively.ithout antigen (control) ( = absolute value of sample with antigen minus absolute
es where mycobacterial PPD was antigen (E–H). Mean values ± SEM, n = at least 7
t; *p < 0.05, **p < 0.01, ***p < 0.001.
Thus, in line with the experiments with KLH as antigen, we
show that PPD loaded macrophages can induce T cell responses
and their ability to do this is dependent on their activation sta-
tus. For both antigens, IFN/LPS activation of macrophages most
readily drives Th1 polarisation, while LPS activation most effec-
tively induces Th17.
DCs and macrophages induce similar levels of Th17 polarisation.
The ready ability of appropriately activated macrophages to
induce Th1, and particularly Th17 responses raised the question
as to whether they are as effective as DCs, which are tradition-
ally believed to be the major drivers of T cells due to their high
expression of HLA-DR and antigen presenting ability (Steinman,
C.E. Arnold et al. / Immunobiology 220 (2015) 10–19 15
Fig. 3. Comparison of T cell responses from cultures with antigen-loaded macrophages or dendritic cells (DC). Differences in proliferation and cytokine levels (as described in
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ntigen minus absolute value of control without antigen. Left panels: Differences w
espective mean values ± SEM, n = 5 different donor preparations. Statistical signiﬁ
012). Therefore, we compared the ability of monocyte derived DCs
nd differentially activated macrophages from the same donor to
rive Th cell responses to presented antigens. Distinct differences
n phenotypic (size, shape, adherence and CD14, HLA-DR, CD11b
nd CD11c expression) and functional characteristics (phagocytic
ctivity) were conﬁrmed for the macrophages and DCs we  derived
Supplementary Figure 3). As expected, DCs activated with LPS or
FN-/LPS stimulated T cell proliferation in response to KLH or PPD,
ith IFN/LPS activation the most effective at inducing IFN (Fig. 3).
omparisons between respective cultures where the APC from the
ame donor preparation were either DC or macrophages and acti-
ated in the same way, supported the view that DCs are superior
o macrophages in driving Th1 differentiation (Fig. 3). By contrast,
owever, despite much higher T cell proliferation induced by DCs,
acrophages and DCs were equally efﬁcient at driving Th17 dif-
erentiation based on secretion of IL-17A, which was  highest when
ither cell type was activated with LPS. Even if the macrophage
nd DC phenotypes we  have studied do not precisely recapitulate
hose in vivo, we have nevertheless established the principle that
ifferential activation of the APC contributes to the type of T cell
esponse. Thus, macrophages, which are more prominent at sites
f inﬂammation, have the potential to be the most effective APC
ype in driving local Th17 responses.hages or DCs without antigen (control). Results show absolute value of sample with
KLH was  antigen; Right panels: Differences where mycobacterial PPD was antigen.
was tested using paired t-tests (*p < 0.05).
Different activating stimuli trigger distinct levels of T cell
polarising cytokines
Antigen-loaded human macrophages and DCs, activated by dis-
tinct stimuli, were shown to induce Th1 and Th17 cell responses
with different efﬁciencies. To determine how this related to their
secretion of polarising cytokines, the levels of IL-12 (associated
with Th1) and IL-1, IL-6, IL-23 (associated with Th17) were mea-
sured in supernatants of antigen-loaded, differentially activated
macrophages or DCs 24 h post activation. IL-12 was upregulated
only in the supernatants of either APC type after IFN/LPS-
activation, consistent with the efﬁcient polarisation to Th1 IFN
responses seen under these conditions. Similarly, macrophages and
DCs showed signiﬁcant increases in IL-1 secretion following acti-
vation with LPS or IFN/LPS (Fig. 4), with LPS the more effective
stimulus, mirroring the ability to induce Th17 responses. LPS or
IFN/LPS also induced both APC types to secrete IL-6 and IL-23,
with macrophages producing higher levels of IL-23 than DCs. By
contrast, the activation of neither macrophages nor DCs with IL-4
upregulated secretion of any of the cytokines studied, as would be
predicted from the poor ability of such cells to induce Th responses.
The role of IL-1 in driving human Th17 polarisation is sup-
ported by experiments based on anti-CD3/CD28 activation of T cells
16 C.E. Arnold et al. / Immunobiology 220 (2015) 10–19
Fig. 4. Different activating stimuli trigger distinct levels of T cell polarising cytokines. T cell polarising cytokines in supernatants of activated macrophages (A, C, E & G)
(n  = 8) or DCs (B, D, F & H) (n = 6). Supernatants were harvested 24 h after stimulation and were analysed for cytokines by cytometric bead array (IL-1, IL-6, IL-12p70) and
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aLISA  (IL-23). Statistical signiﬁcance was determined using a paired t-test (*p < 0.
on-activated control macrophages or DCs.
ith the addition of monocyte-derived supernatant or cytokines,
n the presence or absence of IL-1 and/or IL-1 neutralising anti-
odies (Evans et al., 2009; Lee et al., 2010; Segura et al., 2013).
o address whether the enhanced Th17 production with our LPS-
ctivated macrophages was dependent on the high levels of IL-1
easured, the cytokine was neutralised with antibody. In LPS-
ctivated macrophage co-cultures, which supported the highest
h17 responses, anti-IL-1 antibody signiﬁcantly reduced mean
L-17A levels (Fig. 5). However, there was no such effect when
acrophages were activated with IFN/LPS, where there is a more
rominent Th1 response, IL-17a levels are lower, and IFN may
uppress IL-1 production (Eigenbrod et al., 2013). The antibody
lone did not activate macrophages to induce T cell responses < 0.01) and differences represent levels of cytokine compared to antigen loaded,
(Fig. 5) and neutralising IL-1 in co-cultures had negligible effects
on T cell proliferation, or the secretion of IFN or IL-10. Taken
together, these results focus attention on the role IL-1 produced
by LPS-activated human macrophages in preferentially polarising
Th17 cells.
Discussion
This report addresses a gap in the understanding of the inter-
relationships between macrophage and Th subsets, by directly
comparing the efﬁciency with which antigen presentation by dif-
ferentially activated human macrophages drives each of the major
types of Th cell response. We demonstrated that the induction
C.E. Arnold et al. / Immunobio
Fig. 5. Determination of the importance of IL-1 for human Th17 differentiation.
Soluble IL-1 was  inhibited by supplementation of anti-IL-1 antibody (10 g/mL)
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icant increase in IL-1 secretion from macrophages, which wasn  respective cultures at the beginning of co-culture. Results are mean ± SEM; n = 7.
tatistical signiﬁcance was determined using paired t-tests (*p < 0.05).
f Th proliferation, and the bias towards particular Th subsets,
s strongly dependent on the activation state of macrophages
resenting antigen and the mediators they produce. In
articular, LPS-activated macrophages were most efﬁcient at
timulating IL-17A Th responses, associated with their production
f IL-1, while IFN/LPS activation induced the highest levels of
FN secretion by T cells. By contrast, IL-4 activated macrophages
id not induce signiﬁcant Th proliferation, or secretion of IFN
r IL-17A, in line with their recognised anti-inﬂammatory and
issue reparative nature (Gordon and Taylor, 2005; Murray andlogy 220 (2015) 10–19 17
Wynn, 2011). LPS-activated macrophages were at least as potent
at inducing IL-17A as the corresponding DCs, raising the prospect
that such macrophages make an important contribution to driving
Th17 responses to antigen in inﬂamed sites in vivo. This is sup-
ported by the correlation reported between macrophage but not
DC numbers and Th17 cells in inﬂammation (Allam et al., 2011).
The few studies to date on the role of activated human
macrophages in driving Th cell responses have analysed mito-
genic T cell activation/co-stimulation in the presence of polarising
factors, rather than the speciﬁc responses to presented cognate
antigen that are relevant in vivo. In one report, M2  macrophages
suppressed CD4+ T cell proliferation in mice by depleting arginine,
which is required to induce such responses (Pesce et al., 2009),
while another study demonstrated that human macrophages, in a
mixed lymphocyte reaction, could induce both Th1 and Th17 sub-
sets (Krausgruber et al., 2011). Other important studies showed
that, monocytes activated with LPS or isolated from the inﬂamed
synovium (synovial ﬂuid) of arthritic patients supported efﬁcient
expansion of allogenic Th17, but not Th1 or Th2, responses to
anti-CD3 antibody (Evans et al., 2007, 2009). In contrast, our
study systematically compared the ability of antigen-loaded, dif-
ferentially activated human macrophages to induce autologous
speciﬁc Th cell responses. We  showed that LPS- and IFN/LPS acti-
vated macrophages favoured Th1 and Th17 activation respectively
against both primary and recall antigen, while IL-4 activated M2
type macrophages were relatively ineffective in eliciting these
responses.
DCs are potent APCs and, as predicted, were more efﬁcient than
macrophages in inducing PPD- and KLH-speciﬁc T cell proliferation
and IFN secretion, indicating their superiority in driving Th1 dif-
ferentiation. Importantly, however, macrophages and DCs did not
differ in their ability to drive antigen-dependent Th17 differenti-
ation. This result, using speciﬁc antigen stimulation, is resonant
of reports that human monocytes are more effective than DCs
in supporting the expansion of allogenic lymphocytes stimulated
with anti-CD3, and that monocyte-derived factors efﬁciently drive
Th17 polarisation (Acosta-Rodriguez et al., 2007; Evans et al., 2007,
2009). However, monocytes and macrophages have different roles
and locations in vivo, and our data show for the ﬁrst time how differ-
entially macrophages presenting antigen in, for example, inﬂamed
sites, have the potential to bias the Th response.
One study that did directly investigate antigen-dependent
Th17 polarisation by macrophages was performed on fungal-
activated cells (Cheng et al., 2011). Fungal stimuli have a strong
ability to bias antigen responses to Th17 (Vautier et al., 2010)
through their ligation of innate pattern recognition receptors
such as dectin-1, TLRs and the mannose receptor on APC. Similar
to the LPS-activated macrophages we studied, fungally stimu-
lated macrophages induced strong Th IL-17A production, but
weaker IFN responses. Interactions between other TLR4 agonists
such as saturated fatty acids and antigen loaded macrophages
in peripheral tissues could therefore contribute locally to Th17
polarisation. Indeed, obesity is associated with increased adi-
pose tissue macrophage inﬁltration, a switch to pro-inﬂammatory
macrophages due, in part, to activation by excessive fatty acids, and
greater numbers of IL-17A producing cells (Fabbrini et al., 2013;
Winer et al., 2009).
During activation by presented antigen, the subset of
human CD4+ T lymphocytes is largely dictated by the cytokine
micro-environment, with, for example, the ability of APCs to secrete
IL-12p70, or a combination of IL-1 and IL-6, favouring Th1 and
Th17 phenotypes, respectively. LPS stimulation induced a signif-higher than that from DCs, an observation which may  help to
explain the ability of these macrophages to support Th17 responses.
The importance of IL-1 in driving Th17 differentiation in our
1 nobio
s
p
(
2
t
2
I
e
a
T
p
t
m
I
e
n
t
m
e
H
m
c
n
n
F
m
a
c
v
2
2
e
t
m
p
T
i
b
a
i
t
o
o
c
C
A
R
(
A
f
28 C.E. Arnold et al. / Immu
ystem is supported by other studies that highlight IL-1 as a key
olarising factor for human Th17 in presence of mitogenic stimuli
Acosta-Rodriguez et al., 2007; Evans et al., 2009; Gerosa et al.,
008; Lasigliè et al., 2011), experiments based on Mycobacterium
uberculosis-dependent T cell polarisation (van de Veerdonk et al.,
010) and C. albicans-induced Th17 responses (Hise et al., 2009).
FN/LPS-activated macrophages secreted signiﬁcantly lower lev-
ls of IL-1, but higher levels of IL-12, than after LPS stimulation
lone, again consistent with the shift from supporting Th17 to
h1 responses. One explanation for this fall in IL-1 production is
rovided by a recent report that IFN- suppresses the transcrip-
ion of IL-1, but not of TNF, IL-6, or IL-12p40 in LPS-activated
acrophages, by selectively inhibiting binding of NF-B p65 to the
L-1 promoter (Eigenbrod et al., 2013).
The identiﬁcation of different levels of gene-speciﬁc mRNA
xpression by our LPS, IFN/LPS and IL-4 activated macrophages
ot only validates their distinct phenotypes, but also contributes
o the sparse literature on polarisation markers for human
acrophages (Ambarus et al., 2012; Jaguin et al., 2013; Vogel
t al., 2014). We  show strongly upregulated levels of TNF, IL-6,
LA DR and SOCS3 mRNA in LPS and IFN/LPS activated human
acrophages, but not IL-4 activated cells, which are instead
haracterised by increased expression of TGM2, CISH and man-
ose receptor. These respective proﬁles are consistent with, but
ot identical to, murine M1  and M2  macrophage phenotypes.
or example, although mannose receptor is a key murine M2
acrophage marker, we found its increased expression in IL-4
ctivated human macrophages was less extreme than in mouse
ells, in line with previous reports that the precise proﬁles of acti-
ation markers differ between the two species (Ambarus et al.,
012; Jaguin et al., 2013; Murray and Wynn, 2011; Vogel et al.,
014).
In summary, the results presented here show key differ-
nces in the phenotype and function of activated macrophages
hat inﬂuence T cell responses. They are ﬁrst to identify human
acrophages as efﬁcient APCs that can induce Th1 and Th17
olarisation from T-cells in the absence of mitogenic stimuli.
his might explain the high predominance of Th17 at sites of
nﬂammation where activated macrophages are present as has
een suggested for mouse macrophages (Egan et al., 2008). The
ctivation state of macrophages strongly inﬂuences their Th polar-
sing capacity, raising the prospect that therapeutic interventions
o skew macrophage phenotype could abrogate pathogenic Th1
r Th17 responses in autoimmune and inﬂammatory diseases,
r conversely enhance their polarisation in fungal infection of
ancer.
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